This document summarizes rheumatological aspects of musculoskeletal disorders in hemodialysis patients. It discusses disorders related to dialysis such as dialysis-related amyloidosis, as well as non-crystalline disorders like tendonitis and uremic myopathy. Crystalline disorders covered include gout, pseudogout, and disorders associated with calcium crystals. Specific clinical manifestations are described for many of these conditions. Treatment focuses on optimizing dialysis and medication management. Musculoskeletal ultrasound is highlighted as a useful diagnostic tool. The conclusion discusses a study assessing quality of life and musculoskeletal discomfort in Egyptian hemodialysis patients using validated questionnaires.
Rheumatological aspects in hemodialysis Samar Tharwat
Dr.Samar Tharwat ,Lecturer of Internal Medicine (Rheumatology & Immunology )represents a lecture on rheumatological manifestations in patients with chronic renal failure and on hemodialysis.
Rheumatological aspects in hemodialysis Samar Tharwat
Dr.Samar Tharwat ,Lecturer of Internal Medicine (Rheumatology & Immunology )represents a lecture on rheumatological manifestations in patients with chronic renal failure and on hemodialysis.
Diagnosis, Evaluation, Prevention and Treatment of CKD-MBDAbdullah Ansari
Introduction and definition of CKD–MBD
Diagnosis of CKD–MBD: biochemical abnormalities
Diagnosis of CKD–MBD: bone
Diagnosis of CKD–MBD: vascular calcification
Treatment of CKD–MBD targeted at serum phosphorus and serum calcium
Treatment of abnormal PTH levels in CKD–MBD
Treatment of bone with bisphosphonates, other osteoporosis medications and growth hormone
Evaluation and treatment of kidney transplant bone disease
Treatment Options for Drug-Resistant Epilepsy
In some people with drug resistant epilepsy, there are effective treatment options, with a high chance of seizure freedom. These include:
Resective Epilepsy Surgery
Resective epilepsy surgery consists of removing the area of the brain that is causing the seizures. However, for a patient to be a good candidate for surgery, the following conditions have to be met:
The area of the brain where seizures originate is clearly identified.
That area of the brain can be safely removed with surgery. In other words if the risk is greater than “minimal risk,” the patient is not a candidate.
The probability to achieve seizure freedom with epilepsy surgery varies depending on the structures of the brain involved. For example, patients whose seizures originate in the temporal lobe have a 50% to 70% chance of achieving seizure-freedom.
Today, newer, less-invasive techniques are being used in the place of resective surgery in appropriate cases. These include the use of laser, in which a laser probe burns the area of the brain causing the seizures. However, these new techniques may not work for all candidates for resective surgery.
Specific Metabolic Treatment
While metabolic causes of epilepsy are uncommon, identifying some of these conditions can lead to specific treatments to allow the body to compensate for the metabolic change.
Examples are treatment with a ketogenic diet for GLUT1 deficiency, treatment with pyridoxine or pyridoxal-5-phosphate for vitamin dependent epilepsies, and creatine supplementation for creatine deficiency syndromes.
Specific Genetic Causes
Identifying a specific genetic cause can help your doctor choose the best treatment for seizures.
For example, with SCN1A pathogenic variants, medications such as Oxcarbazepine (Trileptal), Carbamazepine (Tegretol) or Phenytoin (Dilantin) should be avoided. Whereas with other types of pathogenic variants, such as SCN2A and SCN8A variants, these medications can be very helpful.
Some specific treatments which target the underlying problem caused by the genetic variant are in clinical trials, and may improve learning and development as well as help with seizures.
Immunotherapy
In the last decade, the role of inflammatory processes in certain types of epilepsy has been recognized. In these cases, medications that counteract these processes have been used with success. However, they have to be used with caution as they are associated with a variety of adverse events.
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/71ud0njUrFc
Arabic Language version of this lecture is available at:
https://youtu.be/s8dQwB76bFM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Diagnosis, Evaluation, Prevention and Treatment of CKD-MBDAbdullah Ansari
Introduction and definition of CKD–MBD
Diagnosis of CKD–MBD: biochemical abnormalities
Diagnosis of CKD–MBD: bone
Diagnosis of CKD–MBD: vascular calcification
Treatment of CKD–MBD targeted at serum phosphorus and serum calcium
Treatment of abnormal PTH levels in CKD–MBD
Treatment of bone with bisphosphonates, other osteoporosis medications and growth hormone
Evaluation and treatment of kidney transplant bone disease
Treatment Options for Drug-Resistant Epilepsy
In some people with drug resistant epilepsy, there are effective treatment options, with a high chance of seizure freedom. These include:
Resective Epilepsy Surgery
Resective epilepsy surgery consists of removing the area of the brain that is causing the seizures. However, for a patient to be a good candidate for surgery, the following conditions have to be met:
The area of the brain where seizures originate is clearly identified.
That area of the brain can be safely removed with surgery. In other words if the risk is greater than “minimal risk,” the patient is not a candidate.
The probability to achieve seizure freedom with epilepsy surgery varies depending on the structures of the brain involved. For example, patients whose seizures originate in the temporal lobe have a 50% to 70% chance of achieving seizure-freedom.
Today, newer, less-invasive techniques are being used in the place of resective surgery in appropriate cases. These include the use of laser, in which a laser probe burns the area of the brain causing the seizures. However, these new techniques may not work for all candidates for resective surgery.
Specific Metabolic Treatment
While metabolic causes of epilepsy are uncommon, identifying some of these conditions can lead to specific treatments to allow the body to compensate for the metabolic change.
Examples are treatment with a ketogenic diet for GLUT1 deficiency, treatment with pyridoxine or pyridoxal-5-phosphate for vitamin dependent epilepsies, and creatine supplementation for creatine deficiency syndromes.
Specific Genetic Causes
Identifying a specific genetic cause can help your doctor choose the best treatment for seizures.
For example, with SCN1A pathogenic variants, medications such as Oxcarbazepine (Trileptal), Carbamazepine (Tegretol) or Phenytoin (Dilantin) should be avoided. Whereas with other types of pathogenic variants, such as SCN2A and SCN8A variants, these medications can be very helpful.
Some specific treatments which target the underlying problem caused by the genetic variant are in clinical trials, and may improve learning and development as well as help with seizures.
Immunotherapy
In the last decade, the role of inflammatory processes in certain types of epilepsy has been recognized. In these cases, medications that counteract these processes have been used with success. However, they have to be used with caution as they are associated with a variety of adverse events.
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/71ud0njUrFc
Arabic Language version of this lecture is available at:
https://youtu.be/s8dQwB76bFM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
When to Suspect Autoimmune or Rheumatic DiseaseSamar Tharwat
Rheumatic diseases are presented with many many manifestations .It is important to be oriented with these manifestations for early diagnosis and treatment
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Rheumatological aspects in hemodialysis patients 2019
1. RheumatologicalAspects in Hemodialysis Patients
Samar Tharwat Radwan
Lecturer of Internal Medicine
(Rheumatology & Immunology )
Musculoskeletal Ultrasound –EULAR
Mansoura University
2. Introduction
Two million people suffer from ESRD worldwide
The number continues to increase at a rate of 5-7% per year.
Transplantation and dialysis are the main treatment options
Hemodialysis is the most common type of dialysis (90%)
Life expectancy improved with the improvement of this modality.
Musculoskeletal disorders become a major problem in long term hemodialysis patients.
https://pharm.ucsf.edu/kidney/need/statistics
6. Dialysis Related
Amyloidosis
Tissue deposition of beta2-
microglobulin (beta2-m) amyloid
Kaneko, S., & Yamagata, K. (2018, November). Hemodialysis‐related amyloidosis: Is it still relevant?. In Seminars in dialysis
8. Dialysis
Related
Amyloidosis
Risk Factors
increasing age and dialysis duration
low-flux dialysis membranes
lack of residual renal function
Gejyo, F., & Narita, I. (2003). Current clinical and pathogenetic understanding of β2‐m amyloidosis in long‐term haemodialysis patients. Nephrology
9. DialysisRelated
Amyloidosis
Clinical Manifestations
Scarpioni, R., Ricardi, M., Albertazzi, V., De Amicis, S., Rastelli, F., & Zerbini, L. (2016). Dialysis-related amyloidosis: challenges and solutions. International journal of nephrology and renovascular disease,
Shoulder pain
Shoulder pad sign Glenohumeral
joint amyloidosis
Humeral head
erosion
Totally destroyed
humeral head
Rotator cuff tear
11. DialysisRelated
Amyloidosis
Clinical Manifestations
CarpalTunnelSyndrome
• Numbness and dysesthesias in the distribution of the median nerve
• More commonly on the side of the longest-functioning vascular access
• Worsen during dialysis session
• Weakness and atrophy of the muscles of the thenar eminence.
Park, H., Lee, D. S., Yun, T. K., & Ahn, D. S. (2015). Carpal Tunnel Syndrome in Patients Undergoing Long-Term Hemodialysis Therapy: Clinical Characteristics and Results of Surgical Treatment. Journal of the Korean Society for Surgery of the Hand
12. DialysisRelated
Amyloidosis
Clinical Manifestations
Flexor tendons • Amyloid deposition along flexor tendons.
• Irreducible flexion contractures of the fingers
“Guitar string" sign Amyloid hand
CLEVELAND, B. (1999). Beta2^ microglobulin amyloidosis in renal failure: Understanding this recently recognized condition. Cleveland Clinic journal of medicine.
13. DialysisRelated
Amyloidosis
Clinical Manifestations
Neck Pain
Endplate
irregularities
Multiple erosions
at the vertebra
Vertebral
destruction
Lee, G. K., Kang, I. W., Min, S. J., Cho, S. W., Kim, S. W., Jang, W. Y., ... & Suh, K. J. (2006). A case of dialysis-related amyloidosis of the hip and cervical spine: imaging findings. Journal of the Korean Radiological Society
Destructive spondyloarthropathy
DD: infectious diskitis.
14. DialysisRelated
Amyloidosis
Clinical Manifestations
Epidural deposition
Epidural deposition of beta2-m amyloid may compress the
spinal cord, causing quadriparesis or quadriplegia
Vignes, J. R., Eimer, S., Dupuy, R., Donois, E., & Liguoro, D. (2007). β 2-Microglobulin amyloidosis caused spinal cord compression in a long-term haemodialysis patient. Spinal Cord, 45(4), 322.
15. DialysisRelated
Amyloidosis
Clinical Manifestations
Bone cysts
Carpal bones Patella Femoral neck
Nishi, S., Yamamoto, S., Hoshino, J., Takaichi, K., & Naiki, H. (2019). The features of bone articular lesions in dialysis-related amyloidosis (DRA) and criteria for the clinical diagnosis of DRA. Renal Replacement Therapy
• Rapid rate of enlargement
• Pathologic fractures, particularly of the femoral neck
18. DialysisRelatedAmyloidosis:Diagnosis
Biopsy remains the "gold standard"
Acellular glassy pink
amorphous material
Congo red stain
showing apple-green
birefringence
Positive immunohistochemistry
stain confirming β2-
microglobulin amyloidosis
Mendoza, P. D., Fenves, A. Z., Punar, M., & Stone, M. J. (2010, April). Subcutaneous β2-Microglobulin Amyloid Shoulder Nodules in a Long-Term Hemodialysis Patient. In Baylor University Medical Center Proceedings
19. Dialysis-related
Amyloidosis (DRA):
Treatment
Hemodialysis
• biocompatible membranes
• high-flux membranes
• ??super-flux membranes
• increase the dialysis duration
• Increase frequency
• nocturnal or short daily hemodialysis
Peritoneal
dialysis
• insufficient data
Other therapies
• beta2-m column
• doxycycline 100 mg daily
Surgery &
analgesics
• Shoulder
Carpal tunnel surgery
Curettage and bone grafting of amyloid cysts
Joint replacement
20. Dialysis-relatedAmyloidosis (DRA):Treatment
RenalTransplantation is the definite treatment
Scarpioni, R., Ricardi, M., Albertazzi, V., De Amicis, S., Rastelli, F., & Zerbini, L. (2016). Dialysis-related amyloidosis: challenges and solutions. International journal of nephrology and renovascular disease
23. Tendonitis
TTT:
• analgesic
• immobilization
• physical therapy
Soyupek, F., Demir, M., Süslü, F. E., Baykal, B., Sezer, M. T., & Yesildag, A. (2013). The upper extremity musculoskeletal complications in dialysis patients: comparison between hemodialysisand peritoneal dialysis. Journal of back and musculoskeletal rehabilitation
Due to:
•2ry hyperparathyroidism
•use of fluoroquinolones
•calcium deposition
25. Spontaneous
tendon rupture
Aetiology
Hyperparathyroidism
Chronic acidosis
Uremic toxin
Malnutrition
B2-amyloidosis
Diagnosis
Ultrasonography
MRI
Moerenhout, Kevin, et al. "Simultaneous Ipsilateral Quadriceps and Triceps Tendon Rupture in a Patient with End-Stage Renal Failure." Case reports in orthopedics 2018 (2018).
26. Olecranon bursitis
Dialysis elbow/ Uremic bursitis
3.3 episodes per 100 person-year
long-term hemodialysis
at the same side of AVF
repeated friction during HD practice
27. Uremic myopathy
• Weakness ,aching of muscles, especially the shoulder or pelvic
girdles (e.g., climbing or descending stairs, cleaning windows, and
reaching for objects on a high shelf)
• 50% of HD patients.
• Multifactorial:Vitamin D deficiency, hyperparathyroidism
• Must be differentiated from uremic neuropathy by NCS
• TTT: adequate dialysis,Vit D , ttt of hyperparathyroidism
Sarraf, P., Kay, J., & Reginato, A. M. (2008). Non-crystalline and crystalline rheumatic disorders in chronic kidney disease. Current rheumatology reports.
28. Nephrogenic systemic fibrosis
Dialysis associated systemic fibrosis.
gadolinium-containing agents (recent or remote)
thickening of the skin
May affect deeper structures: muscle ,fascia , lung
&heart
TTT:
prophylactic
extracorporeal photopheresis
ultraviolet a phototherapy
plasmapheresis
kidney transplantation
29. Nephrogenic systemic fibrosis
Endrikat, J., Dohanish, S., Schleyer, N., Schwenke, S., Agarwal, S., & Balzer, T. (2018). 10 Years of Nephrogenic Systemic Fibrosis: A Comprehensive Analysis of Nephrogenic Systemic Fibrosis Reports Received by a Pharmaceutical Company from 2006 to 2016. Investigative radiology
31. Septic arthritis
Staphylococcus aureus
Diagnosis is challenging
synovial fluidWBCs: not reliable
crystal-induced can coexist
ESR& CRP may be elevated without infection
Difinite diagnosis: synovial fluid culture & polarized light microscopy
McGillicuddy, D. C., Shah, K. H., Friedberg, R. P., Nathanson, L. A., & Edlow, J. A. (2007). How sensitive is the synovial fluid white blood cell count in diagnosing septic arthritis?. The American journal of emergency medicine
SamarTharwat
33. Osteomyelitis
A high index of suspicion is appropriate
Dudareva, M., Ferguson, J., Riley, N., Stubbs, D., Atkins, B., & McNally, M. (2017). Osteomyelitis of the pelvic bones: a multidisciplinary approach to treatment. Journal of bone and joint infection
34. Hemodialysis related Aluminum toxicity
Due to:
• exposure to aluminum in dialysis fluid
• aluminum-containing phosphate binders
C/P:
• bone and muscle pain, fracture, proximal muscle
weakness, osteomalacia
Diagnosis
• serum aluminum concentrations
• deferoxamine stimulation test
• bone biopsy
Cannata‐Andía, Jorge B., and Jose L. Fernández‐Martín. "The clinical impact of aluminium overload in renal failure." Nephrology Dialysis Transplantation 17.suppl_2 (2002): 9-12.
Treatment
• Removal of all sources of aluminum
• Intensive (six days per week) dialysis with high-
flux dialysis
• Deferoxamine
41. Gout
Hyperuricemia.
Small joints as the first metatarsophalangeal
Hyperparathyroidism enhances urate
absorption Hyperuricemia
However, hyperuricemia is attenuated by urate
removal, especially with high-flux hemodialysis.
GoutyTophi at first MTP joint
42. Pseudogout
Calcium Pyrophosphate Dihydrate
crystals
large or medium-sized joints
knees,wrists, hips, and shoulders,
metacarpophalangeal joints..
Accelerated spinal osteoarthritis
43% among HD patients
Due to:
hypercalcemia
hyperphosphatemia
vitamin D deficiency
hyperparathyroidism
iron overload
44. Arthropathy associated with
hydroxy apatite crystals
• HA extraskeletal calcification
late-stage CKD
• may deposit in the small joints of
the hands, wrists, elbows , hips,
and ankles
• shoulders are the joints most
commonly affected.
Schoppet, M., Shroff, R. C., Hofbauer, L. C., & Shanahan, C. M. (2008). Exploring the biology of vascular calcification in chronic kidney disease: what's circulating?. Kidney international
47. Calcium oxalate
• Due to:
Inefficient removal of oxalate by hemodialysis
Vitamin C
• Deposits of oxalate crystals have been in synovium,
tendon sheaths, articular cartilage, and bone
• Polyarticular pain
• Polarizing light microscopy
• Positive alizarin red S staining of CaOX
48. Treatment ofCrystal-InducedArthropathies
Infection must be excluded
Synovial fluid crystals by polarizing light microscopy
The mainstay of therapy
• NSAIDs
• Colchicine :not dialyzable, granulocytopenia, reversible neuropathy,
myopathy...low-dose regimen (0.15–0.3 mg) or an alternate day dosing
regimen (0.3–0.6 mg)
• Corticosteroids
• Adrenocorticotropic hormone (ACTH)
• Hydroxychloroquine
quadriceps tendon rupture
are unable to extend their knees, may have a knee joint
effusion, and have a low-lying patella with a suprapatellar
gap.
Municipal water supplies (which supply water to dialysis facilities) contain a relatively high concentration of aluminum. These concentrations are considered safe for the general population but are toxic for hemodialysis patients. This is because hemodialysis patients are exposed to very large volumes of fluid and have no means to excrete the aluminum that is in the fluid